Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_assertion type Assertion NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_head.
- NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_assertion description "[Low expression of GalNAc-T3 was associated with poorly differentiated tumor, poor pathologic stage, lymph node metastasis, and tumour recurrence in lung adenocarcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_provenance.
- NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_assertion evidence source_evidence_literature NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_provenance.
- NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_assertion SIO_000772 14735190 NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_provenance.
- NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_assertion wasDerivedFrom lhgdn-20090331 NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_provenance.
- NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_assertion wasGeneratedBy ECO_0000203 NP166032.RA0cgEqhC1gyXtU_TMjPAYcQ-weQ_GpTM4clRCNssvAp0130_provenance.